Muarip, Liam .

HRN: 26-94-05  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/23/2026
01/30/2026
IV
300 Mg
Q 6 Hours
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: